F-2 Tablet Famotidine Deucravacitinib
সামান্যIn clinical trials, Deucravacitinib was taken together with several other medicines. None of them made a clinically significant difference to how the body handles Deucravacitinib. The medicines tested were cyclosporine (blocks both Pgp and BCRP), fluvoxamine (blocks CYP1A2), ritonavir (listed as a CYP1A2 inducer), diflunisal (blocks UGT 1A9), pyrimethamine (blocks OCT1), famotidine (an H2 receptor antagonist) and rabeprazole (a proton pump inhibitor). So in these trials, taking famotidine with Deucravacitinib did not meaningfully change how the body handles Deucravacitinib.
প্রভাব খুব কম বা একেবারেই না হওয়ার কথা। সাধারণত কিছু বদলাতে হয় না, তবু আপনি যত ওষুধ খান সবগুলোর কথা ডাক্তার বা ফার্মাসিস্টকে জানান।